Primary research focus: metabolic research involving dual GIP and GLP-1 receptor agonist pathways.

Tirzepatide is commonly studied in laboratory models related to incretin signaling, glucose-response pathways, and body-composition research.

Research use only. Not for human or veterinary use, consumption, diagnosis, treatment, or prevention.